Form 4 for PBYI PUMA BIOTECHNOLOGY, INC.
Accepted 2022-03-15 00:00:00 ET · period of report 2022-03-03 · accession 0001437749-22-006268 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-15 | 2022-03-03 | PBYI | Ludwig Jeffrey Jerome | Chief Commercial Off | A - Grant | $0.00 | +39.1K | 70.5K | +125% | $0 |
| D | 2022-03-15 | 2022-03-03 | PBYI | Ludwig Jeffrey Jerome | Chief Commercial Off | A - Grant | $0.00 | +55.9K | 55.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-03 | A | A | 39,118 | $0.00 | 70,460 | D | — | — | (F1) Subject to the Grantee's continued service with the Company through the applicable vesting date, the Restricted Stock Units shall vest with respect to one-fourth (1/4th) of the Restricted Stock Units on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-03-03 | A | A | 55,882 | $0.00 | 55,882 | D | $2.33 · — to 2032-03-02 | 55,882 Common Stock | (F2) Subject to the Optionee's continued service with the Company through the applicable vesting date, the Option shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares subject thereto on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024. |